Arbor Biotechnologies Appoints Ajim Tamboli as Chief Financial Officer
CAMBRIDGE, Mass., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced the appointment of Ajim Tamboli, CFA, as its Chief Financial Officer.
- CAMBRIDGE, Mass., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced the appointment of Ajim Tamboli, CFA, as its Chief Financial Officer.
- Mr. Tamboli brings over 24 years of health care experience to the role, joining Arbor from Monte Rosa Therapeutics, where he served as Chief Financial Officer.
- “I am thrilled to add Ajim to our leadership team,” said Devyn Smith, Ph.D., CEO of Arbor.
- “I am delighted to join Arbor Bio’s team of changemakers in the realm of gene editing,” said Mr. Tamboli.